GSK3B and osteosarcoma: Several studies also demonstrated that the suppression of GSK3B function decreased tumor cell survival, proliferation and promoted apoptosis in osteosarcoma, pancreatic, gastrointestinal, and glioblastoma cancer cells as well as other aggressive tumors such as urogenital, colon carcinoma, and lung cancer [59–66].